Zhang Zhenhua, Trypsteen Wim, Blaauw Marc, Chu Xiaojing, Rutsaert Sofie, Vandekerckhove Linos, van der Heijden Wouter, Dos Santos Jéssica Cristina, Xu Cheng-Jian, Swertz Morris A, van der Ven Andre, Li Yang
Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, 6525HP, Nijmegen, the Netherlands.
Department of Genetics, University Medical Center Groningen, 9700RB, Groningen, the Netherlands.
BMC Med. 2021 Nov 16;19(1):282. doi: 10.1186/s12916-021-02156-5.
Combination antiretroviral treatment (cART) cannot eradicate HIV-1 from the body due to the establishment of persisting viral reservoirs which are not affected by therapy and reinitiate new rounds of HIV-1 replication after treatment interruption. These HIV-1 reservoirs mainly comprise long-lived resting memory CD4+ T cells and are established early after infection. There is a high variation in the size of these viral reservoirs among virally suppressed individuals. Identification of host factors that contribute to or can explain this observed variation could open avenues for new HIV-1 treatment strategies.
In this study, we conducted a genome-wide quantitative trait locus (QTL) analysis to probe functionally relevant genetic variants linked to levels of cell-associated (CA) HIV-1 DNA, CA HIV-1 RNA, and RNA:DNA ratio in CD4+ T cells isolated from blood from a cohort of 207 (Caucasian) people living with HIV-1 (PLHIV) on long-term suppressive antiretroviral treatment (median = 6.6 years). CA HIV-1 DNA and CA HIV-1 RNA levels were measured with corresponding droplet digital PCR (ddPCR) assays, and genotype information of 522,455 single-nucleotide variants was retrieved via the Infinium Global Screening array platform.
The analysis resulted in one significant association with CA HIV-1 DNA (rs2613996, P < 5 × 10) and two suggestive associations with RNA:DNA ratio (rs7113204 and rs7817589, P < 5 × 10). Then, we prioritized PTDSS2, IRF7, RNH1, and DEAF1 as potential HIV-1 reservoir modifiers and validated that higher expressions of IRF7 and RNH1 were accompanied by rs7113204-G. Moreover, RNA:DNA ratio, indicating relative HIV-1 transcription activity, was lower in PLHIV carrying this variant.
The presented data suggests that the amount of CA HIV-1 DNA and RNA:DNA ratio can be influenced through PTDSS2, RNH1, and IRF7 that were anchored by our genome-wide association analysis. Further, these observations reveal potential host genetic factors affecting the size and transcriptional activity of HIV-1 reservoirs and could indicate new targets for HIV-1 therapeutic strategies.
联合抗逆转录病毒治疗(cART)无法从体内根除HIV-1,因为会形成持续存在的病毒储存库,这些储存库不受治疗影响,并且在治疗中断后会重新启动新一轮的HIV-1复制。这些HIV-1储存库主要由长寿的静息记忆CD4+T细胞组成,在感染后早期形成。在病毒得到抑制的个体中,这些病毒储存库的大小存在很大差异。识别导致或能够解释这种观察到的差异的宿主因素,可能为新的HIV-1治疗策略开辟道路。
在本研究中,我们进行了全基因组数量性状基因座(QTL)分析,以探究与从207名接受长期抑制性抗逆转录病毒治疗(中位数=6.6年)的(白种人)HIV-1感染者(PLHIV)血液中分离出的CD4+T细胞中细胞相关(CA)HIV-1 DNA、CA HIV-1 RNA水平以及RNA:DNA比率相关的功能相关遗传变异。通过相应的液滴数字PCR(ddPCR)测定法测量CA HIV-1 DNA和CA HIV-1 RNA水平,并通过Infinium全球筛选阵列平台检索522,455个单核苷酸变异的基因型信息。
分析得出与CA HIV-1 DNA有一个显著关联(rs2613996,P<5×10),与RNA:DNA比率有两个提示性关联(rs7113204和rs7817589,P<5×10)。然后,我们将PTDSS2、IRF7、RNH1和DEAF1列为潜在的HIV-1储存库调节因子,并验证了IRF7和RNH1的较高表达与rs7113204-G相关。此外,携带该变异的PLHIV中,表明相对HIV-1转录活性的RNA:DNA比率较低。
所呈现的数据表明,CA HIV-1 DNA的量和RNA:DNA比率可通过我们的全基因组关联分析确定的PTDSS2、RNH1和IRF7受到影响。此外,这些观察结果揭示了影响HIV-1储存库大小和转录活性的潜在宿主遗传因素,并可能为HIV-1治疗策略指明新的靶点。